864
Participants
Start Date
Not specified
Primary Completion Date
December 31, 1992
Study Completion Date
December 31, 1992
Tuberculin Purified Protein Derivative
Administered intradermally at 5 TU per 0.1 mL
Clinical Directors Network of Region II, New York
Harlem AIDS Treatment Group / Harlem Hosp Ctr, New York
Bronx Lebanon Hosp Ctr, The Bronx
Addiction Research and Treatment Corp, Brooklyn
Wilmington Hosp / Med Ctr of Delaware, Wilmington
Veterans Administration Med Ctr / Regional AIDS Program, Washington D.C.
Richmond AIDS Consortium, Richmond
Comprehensive AIDS Alliance of Detroit, Detroit
Henry Ford Hosp, Detroit
AIDS Research Alliance - Chicago, Chicago
Louisiana Comm AIDS Rsch Prog / Tulane Univ Med, New Orleans
Portland Veterans Adm Med Ctr / Rsch & Education Grp, Portland
Hill Health Corp, New Haven
North Jersey Community Research Initiative, Newark
Warner Lambert - Parke Davis
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH